Terms of use
Effective date: 18 October 2026
By using Clinariq you accept Apple's Licensed Application End User License Agreement (Standard EULA) and the additional terms below. If they conflict, the Apple EULA prevails.
Intended use
Clinariq is licensed for research-only statistical analysis and reporting. It is not a medical device and must not be used for the diagnosis or treatment of individual patients or for clinical decisions about a patient. See "Intended use and limitations" for details.
Clinariq Pro
- The free version lets you create one study, run its analyses, view the results on screen and use the sample size calculation. Clinariq Pro removes the study limit and unlocks the multivariable model, Table 1, the manuscript text, the ethics committee justification text and PDF, Word, Excel and CSV exports.
- Pro is offered as a monthly or annual subscription or as a one-time lifetime purchase. Prices are shown in the App Store before you buy.
- Payment is charged to your Apple ID when you confirm the purchase. Subscriptions renew automatically for the same period and price unless cancelled at least 24 hours before the end of the current period; renewal is charged within the 24 hours before the period ends.
- You can manage or cancel your subscription in your App Store account settings. If a free trial is offered, you are not charged when you cancel before it ends; any unused part of a trial ends when you buy a subscription.
- Refunds are subject to Apple's terms and are requested through Apple.
Your responsibilities
You are responsible for having the permissions needed to process the data you analyse, for meeting your ethical and legal obligations, and for how you interpret and use the results.
No warranty
Although the methods are tested against reference values, the app is provided "as is". To the extent permitted by law, no express or implied warranty is given that results are error-free or fit for a particular purpose.
Limitation of liability
To the extent permitted by law, Baran Baran is not liable for indirect, incidental or consequential damages arising from use of the app or from decisions based on its results. Statutory consumer rights that cannot be waived are not affected.
Changes
These terms may be updated; the current version is published in the app.